Guangdong Key Laboratory of Nanomedicine, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, PR China.
Biomaterials. 2013 Sep;34(28):6853-61. doi: 10.1016/j.biomaterials.2013.05.071. Epub 2013 Jun 15.
IR-780 iodide is a near-infrared (NIR) fluorescence dye with higher and more stable fluorescence intensity than clinically applied dye indocyanine green (ICG). Meanwhile, IR-780 can be utilized in photothermal therapy with laser irradiation. IR-780 is an important theranostic agent but its lipophilicity limited its application. In this paper, we synthesize multifunctional heparin-folic acid-IR-780 nanoparticles (HF-IR-780 NPs) by self-assembly of the heparin-folic acid conjugate and IR-780 through ultrasonic sound method. The HF-IR-780 NPs exhibit good monodispersity, significant stability, and excellent molecular targeting to folate receptor over-expressing MCF-7 cells. Furthermore, the in vivo biodistribution experiments show that the HF-IR-780 NPs are specifically targeted to the tumor and can be used for tumor imaging. The in vitro cell viability assays and in vivo photothermal therapy experiments indicate that MCF-7 cells or MCF-7 xenograft tumors could be ablated by combining HF-IR-780 NPs with irradiation of an 808 nm laser. The photothermal therapy in vivo with a single-dose treatment has not caused significant adverse effect. The resulted HF-IR-780 NPs are a potential theranostic agent for imaging-guided cancer therapy.
碘代吲哚菁绿(IR-780)是一种近红外(NIR)荧光染料,其荧光强度比临床应用的染料吲哚菁绿(ICG)更高、更稳定。同时,IR-780 可以在激光照射下用于光热治疗。IR-780 是一种重要的治疗诊断试剂,但它的亲脂性限制了它的应用。本文通过超声声化学法,将肝素-叶酸偶联物和 IR-780 自组装成多功能肝素-叶酸-IR-780 纳米粒子(HF-IR-780 NPs)。HF-IR-780 NPs 表现出良好的单分散性、显著的稳定性和对叶酸受体过表达 MCF-7 细胞的优异分子靶向性。此外,体内生物分布实验表明,HF-IR-780 NPs 特异性靶向肿瘤,可用于肿瘤成像。体外细胞活力测定和体内光热治疗实验表明,MCF-7 细胞或 MCF-7 异种移植瘤可以通过 HF-IR-780 NPs 与 808nm 激光照射联合消融。单次治疗的体内光热治疗没有引起明显的不良反应。HF-IR-780 NPs 是一种有潜力的成像引导癌症治疗的治疗诊断试剂。
ACS Appl Mater Interfaces. 2014-5-14
ACS Appl Mater Interfaces. 2017-3-28
ACS Appl Mater Interfaces. 2016-3-2
Beilstein J Nanotechnol. 2024-7-31
Beilstein J Nanotechnol. 2024-2-6